Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers

Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers

Background: the increasing number of COVID-19 vaccines available to the public may trigger hesitancy or selectivity towards vaccination. This study aimed to evaluate the post-vaccination side effects of the different vaccines approved in Germany; Methods: a cross-sectional survey-based study was car...

Full description

Bibliographic Details
Main Authors:	Miloslav Klugar, Abanoub Riad, Mohamed Mekhemar, Jonas Conrad, Mayte Buchbender, Hans-Peter Howaldt, Sameh Attia
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Biology
Subjects:	adverse effects BTN162 vaccine ChAdOx1 COVID-19 vaccine cross-sectional studies COVID-19 vaccines drug-related side effects and adverse reactions
Online Access:	https://www.mdpi.com/2079-7737/10/8/752

Similar Items

Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe
by: Arkadiusz Dziedzic, et al.
Published: (2021-11-01)

Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
by: Abanoub Riad, et al.
Published: (2021-06-01)

Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic
by: Abanoub Riad, et al.
Published: (2021-04-01)

Safety Profile of Homologous and Heterologous Booster COVID-19 Vaccines in Physicians in Quito-Ecuador: A Cross-Sectional Study
by: Nancy Flores-Lastra, et al.
Published: (2023-03-01)

A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine
by: Miki Wada, BMedSc, MD, et al.
Published: (2022-06-01)

Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18–30 Years Old): An Independent Post-Marketing Study
by: Abanoub Riad, et al.
Published: (2021-10-01)

An Immunogenicity Report for the Comparison between Heterologous and Homologous Prime-Boost Schedules with ChAdOx1-S and BNT162b2 Vaccines
by: Alexandre Vallée, et al.
Published: (2021-08-01)

Editorial: COVID-19 Vaccines Safety Tracking (CoVaST): Part I
by: Miloslav Klugar, et al.
Published: (2023-02-01)

Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea
by: Minji Jeon, et al.
Published: (2021-09-01)

Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study
by: Davide Firinu, et al.
Published: (2021-12-01)

Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients
by: Mei-Fen Pai, et al.
Published: (2023-12-01)

Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project
by: Valéria Valim, et al.
Published: (2022-08-01)

Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia
by: Abanoub Riad, et al.
Published: (2021-08-01)

Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A Case Report and Literature Review
by: Chia-Tung Wu, et al.
Published: (2022-04-01)

Bilateral Optic Neuritis after COVID-19 Vaccination: A Case Report
by: Ching-Chih Liu, et al.
Published: (2022-11-01)

Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population
by: Marwa O. Elgendy, et al.
Published: (2022-01-01)

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
by: Jie Wei, et al.
Published: (2023-02-01)

Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India
by: Anil Bhandari, et al.
Published: (2022-01-01)

A systematic review of effectiveness of BNT162b2 mRNA and ChAdOx1 adenoviral vector COVID-19 vaccines in the general population
by: Chinonyerem O. Iheanacho, et al.
Published: (2021-08-01)

Serious events following COVID‐19 vaccination with ChAdOx1 nCoV‐19 vaccine (Vaxzevria): A short case series from Iran
by: Nasim Khajavirad, et al.
Published: (2022-02-01)

Case report: Sudden cardiorespiratory collapse in a healthy male after coronavirus disease 2019 vaccination at a vaccination center
by: Cze Ci Chan, et al.
Published: (2022-09-01)

Oral adverse events following COVID-19 and influenza vaccination in Australia
by: Abanoub Riad, et al.
Published: (2023-08-01)

Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S
by: Bas de Laat, et al.
Published: (2022-07-01)

Temporal association between COVID-19 vaccination and Raynaud’s phenomenon: A case series
by: Marcus Lisy, et al.
Published: (2023-01-01)

Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
by: Azimi M, et al.
Published: (2021-10-01)

Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021
by: Yao Rodion Konu, et al.
Published: (2021-11-01)

NEURO-COVAX: An Italian Population-Based Study of Neurological Complications after COVID-19 Vaccinations
by: Maria Salsone, et al.
Published: (2023-10-01)

Long-Term Antibody Response against SARS-CoV-2 in Health Care Workers: Effectiveness of Homologous and Heterologous Regimens and Their Relation to Systemic Vaccine-Associated Symptoms
by: Helene Kierkegaard, et al.
Published: (2022-09-01)

Palatal petechiae: an uncommon oral adverse effect of COVID-19 vaccine
by: Bhawna Sayare, et al.
Published: (2021-09-01)

BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees
by: Ahmed N. Alghamdi, et al.
Published: (2021-10-01)

Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
by: Nicole L. Messina, et al.
Published: (2023-07-01)

Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
by: Osman O. Radhwi, et al.
Published: (2022-01-01)

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19
by: Dong-In Kim, et al.
Published: (2022-11-01)

Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
by: Matteo Castaldo, et al.
Published: (2022-03-01)

Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac
by: Passakorn Wanchaijiraboon, et al.
Published: (2023-02-01)

Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies
by: Ernest T. Aguinam, MPhil, et al.
Published: (2023-05-01)

Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports
by: Abanoub Riad, et al.
Published: (2022-07-01)

Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report
by: Sandra Emily Stoll, et al.
Published: (2022-07-01)

Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
by: Marek Mikołajczyk, et al.
Published: (2022-12-01)

Recipient-Reported Reactogenicity of Different SARS-CoV-2 Vaccination Regimens among Healthcare Professionals and Police Staff in Germany
by: Katharina Rau, et al.
Published: (2023-06-01)